Immobilization hypercalcemia treatment with pamidronate disodium after spinal cord injury

Archives of Physical Medicine and Rehabilitation

Volumn 80, Issue 9, 1999, Pages 998-1000

  Massagli, Teresa L ^a,b   Cardenas, Diana D ^a,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CALCIUM; ETIDRONIC ACID; FUROSEMIDE; PAMIDRONIC ACID; SODIUM CHLORIDE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG FEVER; FEMALE; FLUID THERAPY; HUMAN; HYPERCALCEMIA; HYPOCALCEMIA; IMMOBILIZATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PARAPLEGIA; QUADRIPLEGIA; SPINAL CORD INJURY;

EID: 0032822928     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9993(99)90050-3     Document Type: Article

References (17)

1. Stewart AF, Adler M, Byers CM, Segre GV, Broadus AE. Calcium homeostasis in immobilization: an example of resorptive hypercalciuria. N Engl J Med 1982;306:1136-40.
2. Gallacher SJ, Ralston SH, Dryburgh FJ, Logue FC, Allam BF, Boyce FF, et al. Immobilization related hypercalcemia - a possible novel mechanism and response to pamidronate. Postgrad Med J 1990;66:918-22.
3. Naftchi NE, Viau AT, Sell GH, Lowman EW. Mineral metabolism in spinal cord injury. Arch Phys Med Rehabil 1980;61:139-42.
4. Latham BB, Osterman J, Lin T, Nankin HR. Immobilization hypercalcemia in an adult patient with pancreatitis and sepsis: case report. J South Carolina Med Assoc 1992;88:570-2.
5. Tori JA, Hill LL. Hypercalcemia in children with spinal cord injury. Arch Phys Med Rehabil 1978;59:443-7.
6. Merli GJ, McElwain GE, Adler AG, Martin JH, Roberts JD, Schnall B, et al. Immobilization hypercalcemia in acute spinal cord injury treated with etidronate. Arch Intern Med 1984;144:1286-8.
7. Maynard FM, Imai K. Immobilization hypercalcemia in spinal cord injury. Arch Phys Med Rehabil 1977;58:16-24.
8. Nussbaum SR. Pathophysiology and management of severe hypercalcemia. Endocrinol Metab Clin North Am 1993;22:343-62.
9. van Zuiden L, Anquist KA, Schachar N, Kastelen N. Immobilization hypercalcemia. Can J Surg 1982;25:646-49.
10. Meythaler JM, Tuel SM, Cross LL. Successful treatment of immobilization hypercalcemia using calcitonin and etidronate. Arch Phys Med Rehabil 1993;74:316-9.
11. Kedlaya D, Brandstater ME, Lee JK. Immobilization hypercalcemia in incomplete paraplegia: successful treatment with pamidronate. Arch Phys Med Rehabil 1998;79:222-5.
12. Fitton A, McTavish D. Pamidronate: a review of its pharmacological properties and therapeutic efficacy in resorptive bone disease. Drugs 1991;41:289-318.
13. Chisholm MA, Mulloy AL, Taylor AT. Acute management of cancer-related hypercalcemia. Ann Pharmacother 1996;30:507-13.
14. Young G, Shende A. Use of pamidronate in the management of acute cancer-related hypercalcemia in children. Med Pediatr Oncol 1998;30:117-21.
15. Profumo RJ, Reese JC, Foy TM, Garibaldi LR, Kane RE. Severe immobilization induced hypercalcemia in a child after liver transplantation successfully treated with pamidronate. Transplantation 1994;57:301-3.
16. Gucalp R, Ritch P, Wiernik PH, Sarma PR, Keller A, Richman SP, et al. Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemia. J Clin Oncol 1992;10:134-42.
17. Machado LE, Flombaum CD. Safety of pamidronate in patients with renal failure and hypercalcemia. Clin Nephrol 1996;45:175-9.